| Tumor microbiome diversity and composition influence pancreatic cancer outcomes E Riquelme, Y Zhang, L Zhang, M Montiel, M Zoltan, W Dong, P Quesada, ... Cell 178 (4), 795-806. e12, 2019 | 988 | 2019 |
| Single-cell transcriptomics of pancreatic cancer precursors demonstrates epithelial and microenvironmental heterogeneity as an early event in neoplastic progression V Bernard, A Semaan, J Huang, FA San Lucas, FC Mulu, BM Stephens, ... Clinical Cancer Research 25 (7), 2194-2205, 2019 | 302 | 2019 |
| Treatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on multimodality therapy completion and survival CWD Tzeng, HST Cao, JE Lee, PWT Pisters, GR Varadhachary, RA Wolff, ... Journal of Gastrointestinal Surgery 18 (1), 16-25, 2014 | 206 | 2014 |
| Optimal future liver remnant in patients treated with extensive preoperative chemotherapy for colorectal liver metastases J Shindoh, CWD Tzeng, TA Aloia, SA Curley, G Zimmitti, SH Wei, ... Annals of surgical oncology 20, 2493-2500, 2013 | 190 | 2013 |
| Predictors of morbidity and mortality after hepatectomy in elderly patients: analysis of 7621 NSQIP patients CWD Tzeng, AB Cooper, JN Vauthey, SA Curley, TA Aloia HPB 16 (5), 459-468, 2014 | 181 | 2014 |
| Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer CWD Tzeng, A Balachandran, M Ahmad, JE Lee, S Krishnan, H Wang, ... Hpb 16 (5), 430-438, 2014 | 170 | 2014 |
| Preoperative radiation therapy with selective dose escalation to the margin at risk for retroperitoneal sarcoma CWD Tzeng, JB Fiveash, RA Popple, J Pablo Arnoletti, SM Russo, ... Cancer 107 (2), 371-379, 2006 | 164 | 2006 |
| Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for … KJ Labori, MH Katz, CW Tzeng, BA Bjørnbeth, M Cvancarova, B Edwin, ... Acta oncologica 55 (3), 265-277, 2016 | 141 | 2016 |
| Mutation status of RAS, TP53, and SMAD4 is superior to mutation status of RAS alone for predicting prognosis after resection of colorectal liver metastases Y Kawaguchi, S Kopetz, TE Newhook, M De Bellis, YS Chun, CWD Tzeng, ... Clinical Cancer Research 25 (19), 5843-5851, 2019 | 134 | 2019 |
| Deleterious effect of RAS and evolutionary high-risk TP53 double mutation in colorectal liver metastases YS Chun, G Passot, S Yamashita, M Nusrat, P Katsonis, JM Loree, ... Annals of surgery 269 (5), 917-923, 2019 | 134 | 2019 |
| Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial AO Kaseb, E Hasanov, HST Cao, L Xiao, JN Vauthey, SS Lee, BG Yavuz, ... The Lancet Gastroenterology & Hepatology 7 (3), 208-218, 2022 | 132 | 2022 |
| Response and survival associated with first-line FOLFIRINOX vs gemcitabine and nab-paclitaxel chemotherapy for localized pancreatic ductal adenocarcinoma G Perri, L Prakash, W Qiao, GR Varadhachary, R Wolff, D Fogelman, ... JAMA surgery 155 (9), 832-839, 2020 | 131 | 2020 |
| Retroperitoneal and intra-abdominal sarcoma JS Liles, CWD Tzeng, JJ Short, P Kulesza, MJ Heslin Current problems in surgery 6 (46), 445-503, 2009 | 131 | 2009 |
| Colorectal liver metastases CWD Tzeng, TA Aloia Journal of Gastrointestinal Surgery 17, 195-202, 2013 | 124 | 2013 |
| ErbB3 expression and dimerization with EGFR influence pancreatic cancer cell sensitivity to erlotinib A Frolov, K Schuller, CWD Tzeng, EE Cannon, BC Ku, JH Howard, ... Cancer biology & therapy 6 (4), 548-554, 2007 | 124 | 2007 |
| Safety and efficacy of portal vein embolization before planned major or extended hepatectomy: an institutional experience of 358 patients J Shindoh, CWD Tzeng, TA Aloia, SA Curley, SY Huang, A Mahvash, ... Journal of Gastrointestinal Surgery 18 (1), 45-51, 2014 | 123 | 2014 |
| Portal vein embolization improves rate of resection of extensive colorectal liver metastases without worsening survival J Shindoh, CWD Tzeng, TA Aloia, SA Curley, G Zimmitti, SH Wei, ... Journal of British Surgery 100 (13), 1777-1783, 2013 | 119 | 2013 |
| Defined clinical classifications are associated with outcome of patients with anatomically resectable pancreatic adenocarcinoma treated with neoadjuvant therapy CWD Tzeng, JB Fleming, JE Lee, L Xiao, PWT Pisters, JN Vauthey, ... Annals of surgical oncology 19, 2045-2053, 2012 | 105 | 2012 |
| Risk of venous thromboembolism outweighs post‐hepatectomy bleeding complications: analysis of 5651 National Surgical Quality Improvement Program patients CWD Tzeng, MHG Katz, JB Fleming, PWT Pisters, JE Lee, EK Abdalla, ... Hpb 14 (8), 506-513, 2012 | 102 | 2012 |
| Long-term outcome of patients undergoing liver transplantation for mixed hepatocellular carcinoma and cholangiocarcinoma: an analysis of the UNOS database V Vilchez, MB Shah, MF Daily, L Pena, CWD Tzeng, D Davenport, ... Hpb 18 (1), 29-34, 2016 | 96 | 2016 |
